Fundz

P95 completes acquisition of Assign DMB, expanding data management and biostatistics services

PRIVATESep 05, 2024

Acquiring Company

P95

Acquired Company

Assign DMB

LeuvenInnsbruckBiotechnologyHealth CareBiotechnologyHealth CareMedical

Description

P95 BV, a leading global provider of epidemiology and clinical solutions with a specialty focus on vaccines and infectious diseases, has announced the acquisition of Assign DMB. This acquisition enhances P95's capacity to implement both clinical and non-interventional studies, with a continued focus on vaccines and infectious diseases, reinforcing its position as a world class leader in clinical research globally.

Quick answer

P95 is acquiring Assign DMB, announced September 5, 2024. P95 is based in Leuven, Flemish Brabant, Belgium.

How much did P95 pay for Assign DMB?
The deal value was not disclosed.
What does P95 do?
P95 is a leading global provider of epidemiology and clinical solutions with a specialty focus on vaccines and infectious diseases.
Where are P95 and Assign DMB based?
P95 is based in Leuven, Flemish Brabant, Belgium. Assign DMB is based in Innsbruck, Tyrol, Austria.
Who are the decision-makers at P95?
Fundz holds 1 contact at P95. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Medical and Biotechnology

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at P95, and when

When P95 changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day P95 raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at P95, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at P95. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

P95

Location

Leuven, Flemish Brabant, Belgium

About

P95 is a leading global provider of epidemiology and clinical solutions with a specialty focus on vaccines and infectious diseases. The company has regional hub offices in Africa, Latin America, North America, and Southeast Asia. P95 offers high-quality services including clinical trials, epidemiology, and real-world evidence. With a team of 300 professionals across 30 countries, it supports various clients, from pharmaceutical companies to public health institutions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment P95 makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Thomas
Likely contact at this company
••••••••@••••••••

See Thomas's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for P95's next move

Learn about Strategic plan

Frequently asked

Who acquired Assign DMB?

Assign DMB was acquired by P95, based in Leuven. The deal was reported on September 5, 2024. P95 is a leading global provider of epidemiology and clinical solutions with a specialty focus on vaccines and infectious diseases. P95 is privately held and operates in Biotechnology.

When did P95 acquire Assign DMB?

P95's acquisition of Assign DMB was reported on September 5, 2024. P95 BV, a leading global provider of epidemiology and clinical solutions with a specialty focus on vaccines and infectious diseases, has announced the acquisition of Assign DMB. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Assign DMB do?

Assign DMB is one of the leading clinical research organisations in Austria offering a broad range of services for all phases of clinical trials. It is privately held, operating in Biotechnology, and is based in Innsbruck.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.